Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasm, Residual × abemaciclib × Clear all

Sponsor

Conditions

Breast Neoplasms 21 Neoplasm Metastasis 9 Carcinoma, Non-Small-Cell Lung 4 Prostatic Neoplasms 3 Neoplasms 3 Sarcoma, Ewing 2 Glioblastoma 2 Brain Neoplasms 2 Urogenital Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Metastatic Castration-Resistant Prostate Cancer 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma 1 Hormone Receptor Positive Breast Cancer 1 Glioma 1 Ependymoma 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1

Interventions

Rituximab 4 blinatumomab 3 Whole-Body Irradiation 2 Lenalidomide 2 Cyclophosphamide 2 Clofarabine 2 treosulfan 1 thymoglobulin 1 sabatolimab 1 peginterferon alfa-2a 1 obinutuzumab 1 midostaurin 1 ixazomib 1 fludarabine phosphate 1 fludarabine 1 eribulin 1 daratumumab 1 acalabrutinib 1 Trastuzumab 1 Tacrolimus 1 Sodium Chloride 1 Peripheral Blood Stem Cell Transplantation 1 Pentostatin 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Magnetic Resonance Imaging 1 Imatinib Mesylate 1 Histamine Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡